BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 8143497)

  • 1. Guillain-Barre syndrome and Campylobacter jejuni infection. A study on the etiological characteristics of Guillain-Barre syndrome in China.
    Yuan JM; Tang J; Chen QT; Xiao L; Hao HJ; Jia ZD; Huang QH; Liu XZ
    Chin Med J (Engl); 1993 Nov; 106(11):845-7. PubMed ID: 8143497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GM1 antibody in Guillain-Barre syndrome after Campylobacter jejuni infection.
    Tang J; Yuan J; Hao H
    Chin Med J (Engl); 1995 Apr; 108(4):262-4. PubMed ID: 7789212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders.
    Enders U; Karch H; Toyka KV; Michels M; Zielasek J; Pette M; Heesemann J; Hartung HP
    Ann Neurol; 1993 Aug; 34(2):136-44. PubMed ID: 8338338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Campylobacter jejuni infection and Guillain-Barré syndrome.
    Rees JH; Soudain SE; Gregson NA; Hughes RA
    N Engl J Med; 1995 Nov; 333(21):1374-9. PubMed ID: 7477117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Five cases of Campylobacter jejuni enteritis accompanied with Guillain-Barré syndrome].
    Yuan JM; Tang J; Hao HJ
    Zhonghua Nei Ke Za Zhi; 1993 Jun; 32(6):375-7. PubMed ID: 8269767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain beta-N-acetylglucosamine residues.
    Kuroki S; Saida T; Nukina M; Haruta T; Yoshioka M; Kobayashi Y; Nakanishi H
    Ann Neurol; 1993 Mar; 33(3):243-7. PubMed ID: 8498807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Campylobacter jejuni/C.coli infection in patients with Guillain-Barré syndrome by serology and culture.
    Hariharan H; Naseema K; Kumaran C; Shanmugam J; Nair MD; Radhakrishnan K
    New Microbiol; 1996 Jul; 19(3):267-71. PubMed ID: 8841044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndrome.
    Mishu B; Ilyas AA; Koski CL; Vriesendorp F; Cook SD; Mithen FA; Blaser MJ
    Ann Intern Med; 1993 Jun; 118(12):947-53. PubMed ID: 8489109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Campylobacter jejuni infection with childhood Guillain-Barré syndrome: a case-control study.
    Kalra V; Chaudhry R; Dua T; Dhawan B; Sahu JK; Mridula B
    J Child Neurol; 2009 Jun; 24(6):664-8. PubMed ID: 19491112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guillain-Barré syndrome: association with Campylobacter jejuni and Mycoplasma pneumoniae infections in India.
    Gorthi SP; Kapoor L; Chaudhry R; Sharma N; Perez-Perez GI; Panigrahi P; Behari M
    Natl Med J India; 2006; 19(3):137-9. PubMed ID: 16836263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry.
    Oomes PG; Jacobs BC; Hazenberg MP; Bänffer JR; van der Meché FG
    Ann Neurol; 1995 Aug; 38(2):170-5. PubMed ID: 7654064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis.
    Vriesendorp FJ; Mishu B; Blaser MJ; Koski CL
    Ann Neurol; 1993 Aug; 34(2):130-5. PubMed ID: 8338337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association study between an outbreak of Guillain-Barre syndrome in Jilin, China, and preceding Campylobacter jejuni infection.
    Zhang M; Li Q; He L; Meng F; Gu Y; Zheng M; Gong Y; Wang P; Ruan F; Zhou L; Wu J; Chen L; Fitzgerald C; Zhang J
    Foodborne Pathog Dis; 2010 Aug; 7(8):913-9. PubMed ID: 20455754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of preceding Campylobacter jejuni infection by polymerase chain reaction in patients with Guillain-Barré syndrome.
    Sinha S; Prasad KN; Pradhan S; Jain D; Jha S
    Trans R Soc Trop Med Hyg; 2004 Jun; 98(6):342-6. PubMed ID: 15099989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case-control study on Guillain-Barre syndrome in children of North China].
    Wu Z; Wu H; Wang Q; Zhaori G; Wang C; Liang Z; Shan G; Cui S; Pan L; Zheng J; Zuo Q; Zhang Y; Zhang K
    Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Sep; 33(5):279-81. PubMed ID: 11864491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody responses to Campylobacter infections determined by an enzyme-linked immunosorbent assay: 2-year follow-up study of 210 patients.
    Strid MA; Engberg J; Larsen LB; Begtrup K; Mølbak K; Krogfelt KA
    Clin Diagn Lab Immunol; 2001 Mar; 8(2):314-9. PubMed ID: 11238214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathology of the motor-sensory axonal Guillain-Barré syndrome.
    Griffin JW; Li CY; Ho TW; Tian M; Gao CY; Xue P; Mishu B; Cornblath DR; Macko C; McKhann GM; Asbury AK
    Ann Neurol; 1996 Jan; 39(1):17-28. PubMed ID: 8572662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in the research on the pathogenic role of Campylobacter jejuni in Guillain-Barre syndrome].
    Tang J; Yuan JM
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Dec; 25(6):375-7. PubMed ID: 1305004
    [No Abstract]   [Full Text] [Related]  

  • 19. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.
    Jacobs BC; van Doorn PA; Schmitz PI; Tio-Gillen AP; Herbrink P; Visser LH; Hooijkass H; van der Meché FG
    Ann Neurol; 1996 Aug; 40(2):181-7. PubMed ID: 8773599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.
    Funakoshi K; Koga M; Takahashi M; Hirata K; Yuki N
    J Neurol Sci; 2006 Jul; 246(1-2):163-8. PubMed ID: 16600306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.